Literature DB >> 27358677

How does epidemiological and clinicopathological features affect survival after gastrectomy for gastric cancer patients-single Egyptian center experience.

Ehab El Hanafy1, Ayman El Nakeeb1, Helmy Ezzat1, Emad Hamdy1, Ehab Atif1, Tharwat Kandil1, Amgad Fouad1, Mohamed Abdel Wahab1, Ahmed Monier1.   

Abstract

AIM: To investigate the clinicopathological features and the significance of different prognostic factors which predict surgical overall survival in patients with gastric carcinoma.
METHODS: This retrospective study includes 80 patients diagnosed and treated at gastroenterology surgical center, Mansoura University, Egypt between February 2009 to February 2013. Prognostic factors were assessed by cox proportional hazard model.
RESULTS: There were 57 male and 23 female. The median age was 57 years (24-83). One, 3 and 5 years survival rates were 71%, 69% and 46% respectively. The median survival was 69.96 mo. During the follow-up period, 13 patients died (16%). Hospital morbidity was reported in 10 patients (12.5%). The median number of lymph nodes removed was 22 (4-41). Lymph node (LN) involvement was found in 91% of cases. After R0 resection, depth of wall invasion, LN involvement and the number (> 15) of retrieved LN, LN ratio and tumor differentiation predict survival. In multivariable analysis, tumor differentiation, curability of resection and a number of resected LN superior to 15 were found to be independent prognostic factors.
CONCLUSION: Surgery remains the cornerstone of treatment. Tumor differentiation, curability of resection and a number of resected LN superior to 15 were found to be independent prognostic factors. Extended LN dissection does not increase the morbidity or mortality rate but markedly improves long term survival.

Entities:  

Keywords:  Cancer stomach; Lymph node metastasis; Lymph node ratio; Prognostic factors; Recurrence after gastrectomy

Year:  2016        PMID: 27358677      PMCID: PMC4919712          DOI: 10.4240/wjgs.v8.i6.444

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  41 in total

1.  The superiority of ratio-based lymph node staging in gastric carcinoma.

Authors:  Kentaro Inoue; Yasushi Nakane; Hitoshi Iiyama; Mutsuya Sato; Tatsuya Kanbara; Koji Nakai; Syunichiro Okumura; Keigo Yamamichi; Koshiro Hioki
Journal:  Ann Surg Oncol       Date:  2002 Jan-Feb       Impact factor: 5.344

2.  Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer.

Authors:  Erhan Reis; Nuri Aydin Kama; Mutlu Doganay; Mesut Atli; Mete Dolapci
Journal:  Hepatogastroenterology       Date:  2002 Jul-Aug

3.  Surgery: independent prognostic factor in curable and far advanced gastric cancer.

Authors:  G B Doglietto; F Pacelli; P Caprino; A Sgadari; F Crucitti
Journal:  World J Surg       Date:  2000-04       Impact factor: 3.352

Review 4.  Therapeutic value of lymph node dissection and the clinical outcome for patients with gastric cancer.

Authors:  Yoshihiko Maehara; Yoshihiro Kakeji; Tadashi Koga; Yasunori Emi; Hideo Baba; Kohei Akazawa; Keizo Sugimachi
Journal:  Surgery       Date:  2002-01       Impact factor: 3.982

5.  Results of gastric resection for carcinoma of the stomach: the European experience.

Authors:  G Heberer; R K Teichmann; H J Krämling; B Günther
Journal:  World J Surg       Date:  1988-06       Impact factor: 3.352

6.  Clinical evaluation of lymph node metastasis in gastric cancer defined by the fifth edition of the TNM classification in comparison with the Japanese system.

Authors:  K Fujii; H Isozaki; K Okajima; E Nomura; M Niki; S Sako; N Izumi; H Mabuchi; K Nishiguchi; N Tanigawa
Journal:  Br J Surg       Date:  1999-05       Impact factor: 6.939

7.  Rate of detection of lymph node metastasis is correlated with the depth of submucosal invasion in early stage gastric carcinoma.

Authors:  K Yasuda; N Shiraishi; T Suematsu; K Yamaguchi; Y Adachi; S Kitano
Journal:  Cancer       Date:  1999-05-15       Impact factor: 6.860

8.  Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992.

Authors:  J D Roder; K Böttcher; J R Siewert; R Busch; P Hermanek; H J Meyer
Journal:  Cancer       Date:  1993-10-01       Impact factor: 6.860

9.  The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients.

Authors:  Alberto Marchet; Simone Mocellin; Alessandro Ambrosi; Paolo Morgagni; Domenico Garcea; Daniele Marrelli; Franco Roviello; Giovanni de Manzoni; Annamaria Minicozzi; Giovanni Natalini; Francesco De Santis; Luca Baiocchi; Arianna Coniglio; Donato Nitti
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

10.  Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer.

Authors:  M Degiuli; M Sasako; A Ponti; F Calvo
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

View more
  1 in total

1.  CT volumetry can potentially predict the local stage for gastric cancer after chemotherapy.

Authors:  Zhi Cong Wang; Chen Wang; Ying Ding; Yuan Ji; Meng Su Zeng; Sheng Xiang Rao
Journal:  Diagn Interv Radiol       Date:  2017 Jul-Aug       Impact factor: 2.630

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.